Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure

Seventeen women who were persistently uninfected by human immunodeficiency virus type 1 (HIV-1), despite repeated sexual exposure, and 12 of their HIV-positive male partners were studied for antiviral correlates of nontransmission. Thirteen women had ⩾1 immune response in the form of CD8 cell noncyt...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 185; no. 4; pp. 428 - 438
Main Authors Skurnick, Joan H., Palumbo, Paul, DeVico, Anthony, Shacklett, Barbara L., Valentine, Fred T., Merges, Michael, Kamin-Lewis, Roberta, Mestecky, Jiri, Denny, Thomas, Lewis, George K., Lloyd, Joan, Praschunus, Robert, Baker, Amanda, Nixon, Douglas F., Stranford, Sharon, Gallo, Robert, Vermund, Sten H., Louria, Donald B.
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 15.02.2002
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Seventeen women who were persistently uninfected by human immunodeficiency virus type 1 (HIV-1), despite repeated sexual exposure, and 12 of their HIV-positive male partners were studied for antiviral correlates of nontransmission. Thirteen women had ⩾1 immune response in the form of CD8 cell noncytotoxic HIV-1 suppressive activity, proliferative CD4 cell response to HIV antigens, CD8 cell production of macrophage inflammatory protein-1β, or ELISPOT assay for HIV-1-specific interferon-γ secretion. The male HIV-positive partners without AIDS had extremely high CD8 cell counts. All 8 male partners evaluated showed CD8 cell-related cytotoxic HIV suppressive activity. Reduced CD4 cell susceptibility to infection, neutralizing antibody, single-cell cytokine production, and local antibody in the women played no apparent protective role. These observations suggest that the primary protective factor is CD8 cell activity in both the HIV-positive donor and the HIV-negative partner. These findings have substantial implications for vaccine development.
Bibliography:Present affiliations: Gladstone Institute of Virology and Immunology, University of California, San Francisco (B.L.S. and D.F.N.); Department of Biological Sciences, Mount Holyoke College, South Hadley, Massachusetts (S.S.).
istex:D100DE0D457E6F2A375D34E6DDD357F7C33453CB
ark:/67375/HXZ-44CP41HN-B
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
1573-6613
DOI:10.1086/338830